Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Vet Microbiol ; 171(3-4): 432-5, 2014 Jul 16.
Article in English | MEDLINE | ID: mdl-24629772

ABSTRACT

We aimed at Escherichia coli and Enterobacter cloacae isolates resistant to cephalosporins and fluoroquinolones and Salmonella isolates in wild birds in Arctic Svalbard, Norway. Cloacal swabs of little auks (Alle alle, n=215) and samples of faeces of glaucous gulls (Larus hyperboreus, n=15) were examined. Inducible production of AmpC enzyme was detected in E. cloacae KW218 isolate. Sequence analysis of the 1146 bp PCR product of the ampC gene from this isolate revealed 99% sequence homology with the blaACT-14 and blaACT-5 AmpC beta-lactamase genes. Four, respectively six of the identified single nucleotide polymorphisms generated amino acid substitutions in the amino acid chain. As the ampC sequence polymorphism in the investigated E. cloacae strain was identified as unique, we revealed a novel variant of the ampC beta-lactamase gene blaACT-23.


Subject(s)
Bacterial Proteins/metabolism , Charadriiformes/microbiology , Drug Resistance, Bacterial/genetics , Enterobacter cloacae/genetics , Escherichia coli/genetics , beta-Lactamases/metabolism , Amino Acid Substitution/genetics , Animals , Bacterial Proteins/genetics , Base Sequence , Cloaca/microbiology , DNA Primers/genetics , Enterobacter cloacae/enzymology , Molecular Sequence Data , Norway , Polymerase Chain Reaction/veterinary , Polymorphism, Single Nucleotide/genetics , Sequence Analysis, DNA/veterinary , Svalbard , beta-Lactamases/genetics
2.
Springerplus ; 2(1): 296, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23888268

ABSTRACT

BACKGROUND: Acinetobacter baumannii is an opportunistic pathogen posing an increased risk to hospitalized persons, causing nosocomial pneumonias, urinary tract infections and postoperative infections. METHODS: Between 1 December 2011 and 30 September 2012, strains of Acinetobacter spp. were isolated from clinical samples obtained from hospitalized patients. Susceptibility to antibiotics was determined by the standard microdilution method and phenotypic testing was used to detect the presence of serine carbapenemases and metallo-beta-lactamases. The polymerase chain reaction was used to detect the genes encoding carbapenemases. Pulsed field gel electrophoresis was used to investigate the genetic relationship among the carbapenem resistant isolates of Acinetobacter baumannii. RESULTS: In three strains of Acinetobacter baumannii enzyme OXA-23 was detected. This positive result was confirmed by restriction analysis and sequencing. The study reported an OXA-23-producing strains of Acinetobacter baumannii in the Czech Republic. All three strains isolated from Military Hospital patients had a completely identical restriction profile, indicating clonal spread of a strain carrying serine carbapenemase OXA-23 in this health care facility. Moreover this was the first time the strain was detected in the country in patients who had not stayed abroad.

3.
Pol J Microbiol ; 62(4): 373-6, 2013.
Article in English | MEDLINE | ID: mdl-24730131

ABSTRACT

The strains belonging to Burkholderia cepacia complex are important opportunistic pathogens in immunocompromised patients and cause serious diseases. It is possible to obtain isolates from soil, water, plants and human samples. Taxonomy of this group is difficult. Burkholderia cepacia complex consists of seventeen genomic species and the genetic scheme is based on recA gene. Commonly, first five genomovars occurre in humans, mostly genomovars II and III, subdivision IIIA. Within this study we tested identification of first five genomovars by PCR with following melting analysis and RFLP. The experiments were targeted on eubacterial 16S rDNA and specific gene recA, which allowed identification of all five genomovars. RecA gene appeared as more suitable than 16S rDNA, which enabled direct identification of only genomovars II and V; genomovars I, III and IV were similar within 16S rDNA sequence.


Subject(s)
Burkholderia cepacia/genetics , Genome, Bacterial , Polymerase Chain Reaction/methods , Polymorphism, Restriction Fragment Length , Genetic Variation , Genomics/methods , Species Specificity
4.
Article in English | MEDLINE | ID: mdl-23073519

ABSTRACT

AIM: The study aimed at analyzing ESBL- and AmpC-positive Enterobacteriaceae in the gastrointestinal tracts of university hospital inpatients and persons from the Olomouc Region community, and comparing the results with data from 2007. METHODS: Bacteria were isolated from rectal swabs inoculated onto the ChromID(TM) ESBL selective medium (bioMérieux). Production of ESBL-type beta-lactamases was confirmed by the modified double-disk synergy test and AmpC enzyme production was detected by the AmpC disk test. ESBL- and AmpC-positive isolates were subjected to basic genetic analysis aimed at detecting the bla(TEM), bla(SHV), bla(CTX-M) and bla(AmpC) genes. RESULTS: Over the study period (1 March 2010 - 1 May 2010), a total of 1,279 rectal swabs (70.4% of community subjects) were analyzed on the above medium. The prevalence rates of ESBL-positive Enterobacteriaceae were 8.2% in hospitalized patients and 3.2% in community subjects. Production of the AmpC enzyme was detected in 1.1% of bacterial isolates from the community and in one (0.3%) hospital isolate. Among ESBL, the most frequent genes encoding enzymes were from the CTX-M-1-like genes. Detected AmpC beta-lactamases belonged to the CIT, DHA and EBC groups. CONCLUSION: When compared with the year 2007, the rates of carriers of ESBL-positive bacteria increased in both hospitalized patients (from 3% to 8%) and community subjects (from 1% to 3%) in 2010. Given the fact that production of extended-spectrum beta-lactamases is clinically significant, knowing the epidemiological situation is very important for selecting adequate antibiotic therapy.


Subject(s)
Bacterial Proteins/biosynthesis , Enterobacteriaceae/isolation & purification , Gastrointestinal Tract/microbiology , beta-Lactamases/biosynthesis , Carrier State , Czech Republic , Enterobacteriaceae/enzymology , Humans , Inpatients
5.
Surg Infect (Larchmt) ; 13(3): 159-62, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22612439

ABSTRACT

BACKGROUND: Esophageal cancer is a serious diagnosis that has a relative incidence of 4/100,000 inhabitants in the Czech Republic. This disorder is managed predominantly by surgery. The steps to improving the outcome of treatment include a multifactorial approach. The role of operative technique in improving outcomes seems to have reached its limits. However, antibiotic prophylaxis and the treatment of complicating bacterial infections continue to play important roles. METHODS: A total of 85 patients with strictly defined antibiotic prophylaxis during surgical esophagectomy were included in our study. Bacterial strains were isolated from the patient's clinical materials after operation; only one strain from each patient, the first to be isolated, was tested for antibiotic sensitivity. RESULTS: Infectious complications were observed in 15.3% of patients and the mortality rate from infectious complications reached 30.8%. The most frequently documented complicated infection was pneumonia (69.2%) and the most frequent pathogens were enteric bacteria (56.5%). Some bacterial strains producing extended-spectrum beta-lactamases and AmpC beta-lactamases were found. CONCLUSIONS: The infections in our patient set were of endogenous origin. In cases of pneumonia, it is appropriate to begin with antibiotics effective against enteric bacteria and Pseudomonas aeruginosa.


Subject(s)
Bacteremia/microbiology , Esophageal Neoplasms/surgery , Esophagectomy/adverse effects , Lung Diseases, Fungal/microbiology , Pneumonia, Bacterial/microbiology , Surgical Wound Infection/microbiology , Adult , Aged , Antibiotic Prophylaxis/methods , Bacteremia/prevention & control , Humans , Lung Diseases, Fungal/prevention & control , Mediastinitis/microbiology , Microbial Sensitivity Tests , Middle Aged , Pneumonia, Bacterial/prevention & control , Retrospective Studies , Surgical Wound Infection/prevention & control
6.
Diagn Microbiol Infect Dis ; 71(3): 181-91, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21856106

ABSTRACT

A total of 78 bacterial strains with known ß-lactamases were used to optimize a rapid detection system consisting of multiplex polymerase chain reaction and melting curve analysis to amplify and identify blaTEM, blaSHV, and blaCTX-M genes in a single reaction. Additionally, to evaluate the applicability of this method, 32 clinical isolates of Escherichia coli displaying an extended-spectrum ß-lactamase phenotype from patients hospitalized at intensive care units were tested. Results were analyzed by the Rotor-Gene operating software and Rotor-Gene ScreenClust HRM Software. The individual melting curves differed by a temperature shift or curve shape, according to the presence of ß-lactamase genes. With the use of this method and direct sequencing, blaCTX-M-15-like was identified as the most prevalent ß-lactamase gene. In conclusion, this novel detection system seems to be a suitable tool for rapid detection of present ß-lactamase genes and their characterization.


Subject(s)
Escherichia coli/genetics , Multiplex Polymerase Chain Reaction , beta-Lactamases/genetics , Cross Infection/microbiology , Escherichia coli/isolation & purification , Escherichia coli Infections/microbiology , Humans , Intensive Care Units
7.
Med Sci Monit ; 17(5): BR147-52, 2011 May.
Article in English | MEDLINE | ID: mdl-21525803

ABSTRACT

BACKGROUND: Enterobacteriaceae producing ESBL and AmpC enzymes can be associated with failure of antibiotic therapy and related morbidity and mortality. Their routine detection in microbiology laboratories is still a problem. The aim of this study was to compare the sensitivity of selected phenotypic methods. MATERIAL/METHODS: A total of 106 strains of the Enterobacteriaceae family were tested, in which molecular biology methods confirmed the presence of genes encoding ESBL or AmpC. In ESBL-positive strains, the sensitivity of the ESBL Etest (AB Biodisk) and a modified double-disk synergy test (DDST) were evaluated. AmpC strains were tested by a modified AmpC disk method using 3-aminophenylboronic acid. For simultaneous detection of ESBL and AmpC, the microdilution method with a modified set of antimicrobial agents was used. RESULTS: The sensitivity of the ESBL Etest was 95%; the modified DDST yielded 100% sensitivity for ESBL producers and the AmpC test correctly detected 95% of AmpC-positive strains. The sensitivity of the modified microdilution method was 87% and 95% for ESBL and AmpC beta lactamases, respectively. CONCLUSIONS: The detection of ESBL and AmpC beta lactamases should be based on specific phenotypic methods such as the modified DDST, ESBL Etest, AmpC disk test and the modified microdilution method.


Subject(s)
Enterobacteriaceae/enzymology , Microbial Sensitivity Tests/methods , beta-Lactamases/analysis , Anti-Infective Agents/pharmacology , Bacterial Proteins/analysis , Cephalosporins/pharmacology , Enterobacteriaceae/cytology , Enterobacteriaceae/drug effects , Klebsiella pneumoniae/cytology , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/enzymology , Phenotype , Reference Standards , Sensitivity and Specificity
8.
Curr Microbiol ; 62(6): 1664-70, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21400083

ABSTRACT

Bacterial infections are an important issue in current clinical medicine. The severity of infectious diseases has increased dramatically in recent years, which is also due to increasing numbers of resistant bacteria, including strains producing broad-spectrum beta-lactamases. The study aimed at determining the prevalence of ESBL- and AmpC-positive Enterobacteriaceae at the Department of Neonatology, University Hospital Olomouc. Enterobacteriaceae were isolated from clinical samples from infants hospitalized at the Department of Neonatology, University Hospital Olomouc over a period of 2 years. ESBL- and AmpC-positive isolates were subjected to basic genetic analysis. In the study period, a total of 1,526 isolates of the Enterobacteriaceae family were identified, including 55 (3.6%) cases of the ESBL phenotype and 17 (1.1%) AmpC-positive isolates. Genetic analysis of ESBL-positive isolates revealed a majority of CTX-M enzymes. Among AmpC beta-lactamases, the EBC, CIT, DHA, and MOX types were detected. An Escherichia coli strain was isolated with mutations in the promoter region of the ampC chromosomal gene that are associated with overproduction of the relevant enzyme.


Subject(s)
Bacterial Proteins/metabolism , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae/enzymology , Enterobacteriaceae/isolation & purification , Infant, Newborn, Diseases/microbiology , beta-Lactamases/metabolism , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Czech Republic , Drug Resistance, Bacterial , Enterobacteriaceae/classification , Enterobacteriaceae/genetics , Female , Hospitalization , Hospitals, University/statistics & numerical data , Humans , Infant, Newborn , Male , Microbial Sensitivity Tests , Neonatology , beta-Lactamases/genetics
9.
Klin Mikrobiol Infekc Lek ; 16(5): 152-7, 2010 Oct.
Article in Czech | MEDLINE | ID: mdl-21191872

ABSTRACT

BACKGROUND: bacterial infections have become an important issue in current medicine. Recently, their frequency and severity have significantly increased as a result of the rising number of resistant bacteria. One of important mechanisms of resistance is production of broad-spectrum beta-lactamases, namely the ESBL type. The study aimed at determining the frequency of ESBL-positive Enterobacteriaceae in three large hospitals in Moravia, the eastern part of the Czech Republic. MATERIAL AND METHODS: enterobacteriaceae were isolated from clinical material obtained from patients hospitalized in the University Hospital Olomouc, Teaching Hospital Ostrava and Bata Regional Hospital Zlín throughout 2009. Standard microbiology techniques were used for identification. The production of ESBLs was determined by the modified Double-Disk Synergy Test. ESBL-positive isolates of Escherichia coli from ICU patients were subjected to basic genetic analysis. RESULTS AND CONCLUSION: during the study period, a total of 12,922 strains from the Enterobacteriaceae family were detected. The ESBL phenotype was found in 907 cases, i.e. 7 % of all isolates. The most prevalent species of ESBL-producing Enterobacteriaceae were Klebsiella pneumoniae, Klebsiella oxytoca and Escherichia coli. A comparison of general wards and ICUs revealed a higher percentage of ESBL-positive strains of Klebsiella pneumoniae and a lower proportion of ESBL-positive Escherichia coli isolates in intensive care patients. When assessing the patients' clinical material, ESBL-producing strains were most frequently detected in urine. Genetic analysis of ESBL-positive Escherichia coli strains from ICU patients revealed the CTX-M type of ESBL production in most isolates.


Subject(s)
Cross Infection/epidemiology , Enterobacteriaceae Infections/epidemiology , beta-Lactamases/biosynthesis , Czech Republic/epidemiology , Enterobacteriaceae Infections/enzymology , Enterobacteriaceae Infections/microbiology , Humans , Prevalence
10.
Article in English | MEDLINE | ID: mdl-21293539

ABSTRACT

BACKGROUND: In 1928, the first antibiotic, penicillin, was discovered. That was the beginning of a great era in the development and prescription of antibiotics. However, the introduction of these antimicrobial agents into clinical practice was accompanied by the problem of antibiotic resistance. Currently, bacterial resistance to antibiotics poses a major problem in both hospital and community settings throughout the world. METHODS AND RESULTS: This review provides examples of modern genetic methods and their practical application in the field of extended-spectrum ß-lactamase detection. Since extended-spectrum ß-lactamases are the main mechanism of Gram-negative bacterial resistance to oxyimino-cephalosporins, rapid and accurate detection is requested in common clinical practice. CONCLUSIONS: Currently, the detection of extended-spectrum ß-lactamases is primarily based on the determination of bacterial phenotypes rather than genotypes. This is because therapeutic decisions are based on assessing the susceptibility rather than presence of resistance genes. One of the main disadvantages of genetic methods is high costs, including those of laboratory equipment. On the other hand, if these modern methods are introduced into diagnostics, they often help in rapid and accurate detection of certain microorganisms or their resistance and pathogenic determinants.


Subject(s)
Genetic Techniques , beta-Lactam Resistance , Costs and Cost Analysis , Genetic Techniques/economics , Genetic Techniques/standards , Molecular Biology/methods , beta-Lactam Resistance/genetics
11.
Med Sci Monit ; 15(7): BR202-6, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19564820

ABSTRACT

BACKGROUND: Problematic bacteria in the community include enterobacteria which produce extended-spectrum beta-lactamases. As yet there is no description of the prevalence of these bacteria in persons in the community in the Czech Republic. Therefore the main goal of this study was to determine the prevalence of ESBL-positive enterobacteria in the gastrointestinal tracts of subjects in the community in the Czech Republic. MATERIAL/METHODS: Rectal swabs from the investigated subjects were inoculated onto chromID ESBL selective medium and enterobacteria were identified by the Vitek2 automated system. ESBL were detected using a modified DDST test. The results were confirmed by PCR and direct sequencing of CTX-M-positive amplicons. RESULTS: A total of 579 rectal swabs from subjects in the community were analyzed and ESBL production was both phenotypically and genotypically confirmed in 7 isolates. Thus the prevalence of ESBL-positive bacteria in the gastrointestinal tracts of the persons in the community was 1.2%. All the cases were Escherichia coli strains producing the CTX-M-type ESBL. CTX-M-15 was the most prevalent type in this group of isolates. CONCLUSIONS: The presented results are in accord with other authors' studies and suggest that the epidemiologic profile of ESBL-positive enterobacteria in the Czech Republic is comparable to that in other European countries.


Subject(s)
Enterobacteriaceae/enzymology , Enterobacteriaceae/isolation & purification , Residence Characteristics , beta-Lactamases/metabolism , Bacterial Typing Techniques , Czech Republic , Enterobacteriaceae/classification , Humans , Microbial Sensitivity Tests , Polymerase Chain Reaction , Prevalence
12.
New Microbiol ; 32(1): 67-76, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19382671

ABSTRACT

The aim of the study was to determine the prevalence of Pseudomonas aeruginosa and Klebsiella pneumoniae strains in patients with acute leukemias, to assess their clinical significance, and to define the sources and ways of their spread using genetic analysis. Thirty-four patients were investigated during the observed period. Twenty-one strains of Pseudomonas aeruginosa and 35 strains of Klebsiella pneumoniae were isolated from patient samples. In the case of Pseudomonas aeruginosa, 47.6% of strains were identified as pathogens and caused infection. By contrast, only 4 isolates (11.4%) of Klebsiella pneumoniae could be regarded as etiological agents of bacterial infection. Based on the obtained results, Klebsiella pneumoniae strains are assumed to be of mostly endogenous origin. In the case of Pseudomonas aeruginosa strains, the proportion of identical strains detected in various patients was higher and exogenous sources were more significant. In addition, our results confirmed the ability of Pseudomonas aeruginosa strains to survive on a particular site in the hospital for a longer time.


Subject(s)
Hematologic Neoplasms/complications , Klebsiella Infections , Klebsiella pneumoniae/isolation & purification , Pseudomonas Infections , Pseudomonas aeruginosa/isolation & purification , Anti-Bacterial Agents/pharmacology , Humans , Klebsiella Infections/epidemiology , Klebsiella Infections/microbiology , Klebsiella Infections/transmission , Klebsiella pneumoniae/classification , Klebsiella pneumoniae/genetics , Microbial Sensitivity Tests , Prevalence , Pseudomonas Infections/epidemiology , Pseudomonas Infections/microbiology , Pseudomonas Infections/transmission , Pseudomonas aeruginosa/classification , Pseudomonas aeruginosa/genetics
13.
Klin Mikrobiol Infekc Lek ; 15(1): 4-6, 2009 Feb.
Article in Czech | MEDLINE | ID: mdl-19399723

ABSTRACT

INTRODUCTION: Currently, one of the most serious problems in medicine is the increasing resistance of pathogenic bacteria to antimicrobial drugs. Bacterial resistance may potentially be solved in particular by decreasing the consumption of antibiotics and increasing the quality of their use. Equally important, however, is the development of new antimicrobial drugs and their use in clinical practice. One of the new antibiotic agents is tigecycline of the glycylcycline group. The presented work aimed at assessing its in vitro effect on selected multiresistant bacteria. MATERIAL AND METHODS: Clinical samples were collected from patients hospitalized in the University Hospital Olomouc to isolate ESBL- and AmpC beta-lactamase-producing enterobacteria, methicillin-resistant Staphylococcus aureus (MRSA) strains and vancomycin-resistant enterococci (VRE). In the isolates, susceptibility to tigecycline was determined by the standard microdilution method. RESULTS: A total of 350 isolates were tested (100 MRSA, 10 0 VRE, 100 ESBL-positive and 50 AmpC-positive enterobacteria). In the cases of VRE and MRSA, no resistance to tigecycline was detected and the minimum inhibitory concentrations (MIC) did not exceed 0.25 mg/l and 0.5 mg/l, respectively. In ESBL-positive enterobacteria, 97% susceptibility (MIC range = or <0.06 to 4 mg/l) was detected; in AmpC-positive enterobacteria, the MIC range was = or <0.03-2 mg/l and susceptibility reached 98 %. CONCLUSION: Tigecycline may be considered a suitable alternative in the treatment of infections caused by the above-mentioned multiresistant strains.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Multiple, Bacterial , Enterobacteriaceae/drug effects , Enterococcus/drug effects , Methicillin-Resistant Staphylococcus aureus/drug effects , Minocycline/analogs & derivatives , Vancomycin Resistance/drug effects , Enterobacteriaceae/metabolism , Microbial Sensitivity Tests , Minocycline/pharmacology , Tigecycline , beta-Lactamases/biosynthesis
14.
Klin Mikrobiol Infekc Lek ; 14(5): 173-7, 2008 Oct.
Article in Slovak | MEDLINE | ID: mdl-19051165

ABSTRACT

BACKGROUND: Currently, important bacterial beta-lactamases of increasing clinical significance include AmpC enzymes. The aim was to assess their occurrence in Klebsiella pneumoniae strains isolated from patients with haematological malignancies in a prospective study. MATERIAL AND METHODS: Over a 2-month period, strains of the species were isolated from clinical material obtained from patients hospitalized at the Department of Haemato-Oncology of the University Hospital Olomouc. The strains were identified using standard microbiological techniques and the Vitek 2 automated system. Production of AmpC beta-lactamases was roughly determined by phenotypic tests and subsequently confirmed by PCR detection of genes encoding these enzymes. RESULTS: During the above-mentioned period, a total of 35 K. pneumoniae isolates were collected. In 7 of them, production of AmpC beta-lactamases was preliminarily detected by phenotypic test. The multiplex PCR method confirmed phenotyping and determined DHA types in all the isolates. CONCLUSIONS: All AmpC-positive isolates were false-susceptible to at least one of the tested third-generation cephalosporins. In one patient, clinically apparent infection caused by this strain was documented. The reported results suggest the possibility of occurrence of AmpC-beta-lactamases in K. pneumoniae strains with clinical significance.


Subject(s)
Bacterial Proteins/metabolism , Klebsiella pneumoniae/isolation & purification , Leukemia/microbiology , beta-Lactamases/metabolism , Acute Disease , Humans , Klebsiella pneumoniae/enzymology
15.
Klin Mikrobiol Infekc Lek ; 13(5): 206-12, 2007 Oct.
Article in Slovak | MEDLINE | ID: mdl-17987570

ABSTRACT

OBJECTIVES: The study aimed at the assessment of the prevalence of ESBL-positive isolates of Klebsiella pneumoniae in intensive care patients and their molecular biology analysis. MATERIAL AND METHODS: Over a 5-month period, Klebsiella pneumoniae strains were isolated from patients hospitalized at the Department of Anaesthesiology and Resuscitation of the University Hospital in Olomouc. For each isolate, an antibiogram was performed by the standard microdilution method and the production of ESBL was determined by the modified double-disk synergy test. PCR was used to demonstrate the presence of the blaTEM and blaSHV genes. The isolates producing SHV- and TEM-types of beta-lactamases were typed using the restriction fragment length polymorphism (RFLP) method to identify the most common mutations responsible for the development of an ESBL phenotype. Similar or identical isolates were determined by pulsed-field gel electrophoresis (PFGE) of DNA fragments cleaved by the XbaI restriction endonuclease. RESULTS: A total of 67 isolates of Klebsiella pneumoniae were obtained. In 13 of them, the production of ESBL was detected and the presence of the blaSHV gene was confirmed by PCR. Restriction cleavage by NheI revealed mutations at position 238 in all SHV-positive PCR products. The restriction analysis did not confirm the presence of the gene encoding TEM-type extended-spectrum beta-lactamase. Molecular biology typing by PFGE detected the presence of 11 different strains. CONCLUSIONS: In the observed group of intensive care patients, the prevalence of ESBL-positive strains of Klebsiella pneumoniae reached 19.4 %. The analysis of SHV and TEM products of PCR by the RFLP method showed the prevalence of SHV-type ESBL. Overall, 84.6 % of the strains had unique restriction profiles. The results suggest both high levels of hygienic and epidemiological measures at the monitored department and rational antibiotic policy.


Subject(s)
Klebsiella pneumoniae/enzymology , beta-Lactam Resistance , beta-Lactamases/biosynthesis , Cross Infection/microbiology , Humans , Intensive Care Units , Klebsiella Infections/microbiology , Klebsiella pneumoniae/genetics , Klebsiella pneumoniae/isolation & purification , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , beta-Lactamases/genetics
16.
Article in English | MEDLINE | ID: mdl-16601799

ABSTRACT

The effect of two phenolic compounds vanillin (4-hydroxy-3-methoxybenzaldehyde) and lignin on the development of drug/antibiotic resistance in Salmonella typhimurium was studied. Using the modified Ames test we have shown that vanillin alone has negligible effect on spontaneous mutability to ciprofloxacin and gentamicin resistance. At the tested concentrations vanillin reduces the toxicity of 4-nitroquinoline-N-oxide (4NQO) and reduces the ability of this compound to induce mutations leading to ciprofloxacin but not to gentamicin resistance. Lignin at higher concentrations increases mutagenicity to ciprofloxacin resistance and possess considerable inhibition effect on the spontaneous and 4NQO induced mutability to gentamicin resistance.


Subject(s)
Benzaldehydes/pharmacology , Drug Resistance, Bacterial/drug effects , Lignin/pharmacology , Phenols/pharmacology , Ciprofloxacin/pharmacology , Drug Resistance, Bacterial/genetics , Gentamicins/pharmacology , Mutation/drug effects , Salmonella typhimurium/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...